SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BMO Capital Maintains Market Perform on Pacira BioSciences, Lowers Price Target to $70

BMO Capital analyst Gary Nachman maintains Pacira BioSciences (NASDAQ:PCRX) with a Market Perform and lowers the price target from $72 to $70.

05/10/2021 09:25
BMO Capital analyst Gary Nachman maintains Pacira BioSciences (NASDAQ:PCRX) with a Market Perform and lowers the price target from $72 to $70.